Search HKMJ:

 

Treating genetic disease

NM Hjelm
Department of Chemical Pathology, Prince of Wales Hospital, Shatin, Hong Kong


The treatment of genetic disease has developed over the past thirty years, and includes: the classical approach, which aims to prevent organ damage from excessive amounts of metabolites generated by the metabolic defect or which adds substances that are not synthesised; enzyme replacement therapy, which attempts to introduce a specific enzyme with a normal configuration into organs where the enzyme is missing or malfunctioning because of structural abnormalities; the transplantation of cells, especially bone marrow cells, and whole organs; and somatic gene therapy. The clinical outcomes of attempts to treat genetic disease have only been partially successful. More developmental work is required before the therapies can be said to be effective, especially in the prevention of brain damage.


Hong Kong Med J 1996;2:292-6

Key words: Gene therapy; Gene products; Protein engineering; Genetics, medical; Hereditary diseases; Metabolism, inborn errors; Mental retardation

 
 
View this abstract indexed in MEDLINE:
 

 

The Hong Kong Medical Journal is a continuation of the former Journal of the Hong Kong Medical Association.
The Hong Kong Medical Journal is published by the Hong Kong Academy of Medicine and the Hong Kong Medical Association.
Copyright © 1995-2008 HKAM. All rights reserved.
URL: http://www.hkmj.org
Layout, design, and revisions Copyright © 2008 HKAM.
Revised 8 Oct 2008